Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.30 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL272593 | 0.92 | ALDH1A1 (0.41) | ALDH1A1TSHRSMN1; SMN2TDP1USP2 | |
| SCHEMBL17188274 | 0.88 | ALDH1A1 (0.41) | ALDH1A1TSHRSMN1; SMN2TDP1USP2 | |
| SCHEMBL26661597 | 0.84 | ALDH1A1 (0.38) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL17169885 | 0.82 | TSHR (0.45) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL16134386 | 0.82 | ALDH1A1 (0.37) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| Glycerin SCHEMBL3885371 | 0.81 | ALDH1A1 (0.41) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL13398575 | 0.81 | TSHR (0.41) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL15831677 | 0.81 | TSHR (0.44) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL15831679 | 0.81 | TSHR (0.44) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 | |
| SCHEMBL13399052 | 0.81 | TSHR (0.47) | ALDH1A1TSHRSMN1; SMN2TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | BASF SE (DE) | 2018-08-02 | — | — | US | disclosed |
| US-9921477-B2 | Photoactivable nitrogen bases | BASE SE (DE) | 2018-03-20 | — | — | US | disclosed |
| US-20100105794-A1 | PHOTOACTIVABLE NITROGEN BASES | CIBA CORPORATION (US) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | CBR1, NR0B1, NR0B2 | ALDH1A1 1733/4885TSHR 801/4885SMN1; SMN2 3651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.